Eloxx Pharmaceuticals, Inc. Common Stock ELOX

$18.76 -1.63% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-11 View →
10-Q 10-Q 2026-08-11 View →
4 Insider transaction 2026-06-17 View →
4 4 2026-06-10 View →
4 4 2026-06-10 View →
4 4 2026-06-10 View →
4 4 2026-06-10 View →
4 4 2026-06-10 View →
4 Insider transaction 2026-06-05 View →
8-K 8-K 2026-06-01 View →
4 OWNERSHIP DOCUMENT 2026-05-29 View →
4 4 2026-05-08 View →
4 4 2026-05-08 View →
4 4 2026-05-08 View →
S-1 S-1 2026-05-07 View →
10-Q 10-Q 2026-05-05 View →
8-K 8-K 2026-05-01 View →
10-K 10-K 2026-03-17 View →
8-K FORM 8-K 2025-08-12 View →
4 OWNERSHIP DOCUMENT 2025-01-28 View →
4 OWNERSHIP DOCUMENT 2025-01-28 View →
4 OWNERSHIP DOCUMENT 2025-01-28 View →
4 OWNERSHIP DOCUMENT 2025-01-28 View →
4 OWNERSHIP DOCUMENT 2024-10-17 View →
4 OWNERSHIP DOCUMENT 2024-10-17 View →
4 OWNERSHIP DOCUMENT 2024-10-17 View →
8-K FORM 8-K 2024-10-17 View →
4 OWNERSHIP DOCUMENT 2024-10-17 View →
8-K FORM 8-K 2024-07-16 View →
8-K FORM 8-K 2024-03-29 View →
8-K FORM 8-K 2024-03-14 View →
4 OWNERSHIP DOCUMENT 2024-01-26 View →
4 OWNERSHIP DOCUMENT 2024-01-26 View →
4 OWNERSHIP DOCUMENT 2024-01-26 View →
4 OWNERSHIP DOCUMENT 2024-01-26 View →
S-3 S-3 2024-01-25 View →
8-K FORM 8-K 2024-01-09 View →
8-K FORM 8-K 2023-12-28 View →
8-K FORM 8-K 2023-12-15 View →
8-K FORM 8-K 2023-11-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$18.76
Market Cap
$64.47 million
52-Week Range
$0.00 $19.96
Average Volume
60K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.